Patchy evidence in skin-picking disorder supports management with combined behavioural and drug treatments
Tóm tắt
Skin-picking disorder (SPD) is a common, repetitive, compulsive and distressing disorder with significant psychosocial effects. Data from relatively few clinical trials support behavioural therapies, especially habit-reversal therapy, as the first-line treatment. Depending on the individual’s SPD style and comorbidities, augmenting habit-reversal therapy with other behavioural therapies or pharmacological options, particularly glutamatergic modulators or specific serotonin-reuptake inhibitors, may enhance treatment outcomes.
Tài liệu tham khảo
Jafferany M, Patel A. Skin-picking disorder: a guide to diagnosis and management. CNS Drugs. 2019;33(4):337–46.
Diagnostic and statistical manual of mental disorders (DSM-5). Washington DC: American Psychiatric Association; 2013.
Arnold LM, Auchenbach MB, Mcelroy SL. Psychogenic excoriation. CNS Drugs. 2001;15(5):351–9.
Gupta A, Jafferany M. Psychocutaneous disease. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Lippincott William & Wilkins; 2000.
Koo JYM, Lee CS. General approach to evaluating psychodermatological disorders. In: Koo JYM, Lee CS, editors. Psychocutaneous medicine. New York: Marcel Dekker, Inc.; 2003. p. 1–29.
Jones G, Keuthen N, Greenberg E. Assessment and treatment of trichotillomania (hair pulling disorder) and excoriation (skin picking) disorder. Clin Dermatol. 2018;36(6):728–36.
Gupta M. Body-focused repetitive behaviors (BFRB) (trichotillomania, skin picking, onychophagia) and eating disorders (ED): preliminary findings in a nondermatologic sample. J Am Acad Dermatol. 2016;74(5):46.
Ricketts EJ, Snorrason Í, Kircanski K, et al. A latent profile analysis of age of onset in pathological skin picking. Compr Psychiatry. 2018;87:46–52.
Keuthen NJ, Tung ES, Woods DW, et al. Replication study of the Milwaukee inventory for subtypes of trichotillomania-adult version in a clinically characterized sample. Behav Modif. 2015;39(4):580–99.
Snorrason I, Smári J, Olafsson RP. Emotion regulation in pathological skin picking: findings from a non-treatment seeking sample. J Behav Ther Exp Psychiatry. 2010;41(3):238–45.
Schuck K, Keijsers GP, Rinck M. The effects of brief cognitive-behaviour therapy for pathological skin-picking: a randomised comparison to wait-list control. Behav Res Ther. 2011;49(1):11–7.
Teng EJ, Woods DW, Twohig MP. Habit reversal as a treatment for chronic skin picking: a pilot investigation. Behav Modif. 2006;30(4):411–22.
Flessner CA, Busch AM, Heideman PW, et al. Acceptance enhanced behavior therapy (AEBT) for trichotillomania and chronic skin picking: exploring the effects of component sequencing. Behav Modif. 2008;32(5):579–94.
Schumer MC, Bartley CA, Bloch MH. Systematic review of pharmacological and behavioral treatments of skin picking disorder. J Clin Psychopharmacol. 2016;36(2):147–52.
Selles RR, McGuire JF, Small BJ, et al. A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder. Gen Hosp Psychiatry. 2016;41:29–37.
McFarland K, Lapish CC, Kalivas PW. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behaviour. J Neurosci. 2003;23(3):3531–7.
Grant JE, Odlaug BL, Kim SW. Lamotrigine treatment of pathologic skin picking: an open label study. J Clin Psychiatry. 2007;68(9):1384–91.
Arbabi M, Farnia V, Balighi K, et al. Efficiency of citalopram in treatment of pathological skin picking: a randomized double-blind placebo controlled trial. Acta Med Iran. 2008;46(5):367–72.
Grant JE, Odlaug BL, Chamberlain SR, et al. A double-blind placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol. 2010;30(4):396–403.
Jafferany M, Osuagwu FC. Use of topiramate in skin picking disorder:a pilot study. Prim Care Companion CNS Disord. 2017;19(1).
Sasso DA, Kalanithi PS, Trueblood KV, et al. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors. J Clin Psychopharmacol. 2006;26(6):685–7.
Grant JE, Chamberlain SR, Redden SA, et al. N-Acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(5):490–6.
Keuthen NJ, Jameson M, Loh R, et al. Open label trial of escitalopram treatment for pathological skin picking. Int Clin Psychopharmacol. 2007;22(5):268–74.
Simeon D, Stein DJ, Gross S, et al. A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry. 1997;58(8):341–7.
Bloch MR, Elliott M, Thompson H, et al. Fluoxetine in pathological skin picking: open label and double-blind results. Psychosomatics. 2001;42(4):314–9.
Arnold LM, Mutasim DF, Dwight MM, et al. An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol. 1999;19(1):15–8.
Sharma H. Psychogenic excoriation responding to fluoxetine: a case report. J Indian Med Assoc. 2008;106(4):245–62.